drugs

See the following -

The Holy Grail Of New Drug Development

Rishikesha T. Krishnan | The Hindu Business Line | July 4, 2013

The announcement by Zydus Cadila in early June that their new drug to treat diabetics who also suffer from high cholesterol has passed all stages of clinical trials is an important landmark for the Indian pharmaceutical industry. [...] Read More »

The Open Medicine Institute: Big Plans And A Sense Of Urgency

Sasha | Phoenix Rising | July 1, 2013

Imagine that you’ve just been put in charge of the world’s ME/CFS research – yes, you – and you’ve got to decide what research you want. Come on, hurry up! Read More »

The Threat From Antibiotic Use On The Farm

Donald Kennedy | The Washington Post | August 22, 2013

When I was commissioner of the U.S. Food and Drug Administration (FDA), the agency’s national advisory committee recommended in 1977 that we eliminate an agricultural practice that threatened human health. Routinely feeding low doses of antibiotics to healthy livestock, our scientific advisory committee warned, was breeding drug-resistant bacteria that could infect people. Read More »

Transparency Life Sciences Launches Indication Finder™ Crowdsourcing Tool For Drug Repurposing

Press Release | Transparency Life Sciences (TLS) | October 24, 2012

Transparency Life Sciences (TLS), the world's first drug development company based on open innovation, today announced the launch of Indication Finder™, a survey-based crowdsourcing tool designed to identify promising new indications for existing drug candidates. Read More »

Trial Designed With Crowd Input Gets FDA Signoff

Marc Iskowitz | MM&M | December 28, 2012

What's been called the first clinical study protocol developed using crowdsourcing methods received the FDA's imprimatur earlier this month. The agency approved Transparency Life Sciences' IND for a clinical trial designed to test a generic blood-pressure medication, ACE inhibitor lisinopril, in patients with relapsing remitting multiple sclerosis. Read More »

Two Drug Firms Experiment With Use of Apple's ResearchKit

Todd R. Weiss | eWeek | July 13, 2015

Two major pharmaceutical companies are using Apple's ResearchKit open-source project in experiments aimed at helping medical researchers gain more data and fresh insights as they seek ways to battle human diseases and illnesses. Pharmaceutical company GlaxoSmithKline confirmed its work in a July 10 tweet, saying the company is "looking @ Apple's #ResearchKit for clinical trials," while Purdue Pharma also said it is exploring early possible uses of ResearchKit in its own drug research, according to a July 12 story by Buzzfeed. Read More »

U.S. Consumers Pay More For Drugs

David Sell | Philly.com | April 10, 2013

U.S. consumers and taxpayers usually pay more - often much more - than people in other developed nations for brand-name drugs, according to a series of papers published Monday in the journal  Health Affairs. Read More »

Vendor Tapped without Competition for Key Parts of Defense-VA Pharmacy System

Bob Brewin | Nextgov | June 5, 2012

Buried deep in an ostensibly competitive new procurement for the pharmacy information system to serve the Veterans Affairs and Defense departments’ integrated electronic health record is the fact that VA already has selected a vendor to provide key components of what will become the largest pharmacy management system in the world.

Read More »

What's Tylenol Doing To Our Minds?

James Hamblin | Atlantic | April 18, 2013

The active drug in Tylenol, acetaminophen, is one of the best medications we have for helping people in pain. It's also one the most commonly overdosed substances in the world and puts about 60,000 Americans in the hospital every year. Several hundred people in the U.S. will die in 2013 from liver failure after acetaminophen overdose. Read More »

Why Branding Obesity As A Disease Is A Step In The WRONG Direction...

Joseph Mercola | Mercola.com | July 6, 2013

The documentary film Hungry For Change1 is another revolutionary look at food and nutrition from the creators of the best-selling film Food Matters. Read More »

Why Do Medicare, Medicaid And Veterans Affairs Deal With Drug Costs Differently?

David Sell | Philly.com | April 9, 2013

Countries sometimes do things differently from other countries or gain reputations for doing certain things well or poorly. But within a country, within the same federal government, does it make sense to do things differently among departments or programs that are providing essentially the same service? Read More »

Why Is American Health Care So Ridiculously Expensive?

Derek Thompson | The Atlantic | March 27, 2013

It would be nice to say that high prices are a bug of our medical system. But they're a feature. They're part of a choice we've made. Read More »

Why Medicare Cuts Will Quietly Kill Seniors

Michael L. Millenson | The Health Care Blog | April 8, 2013

The recent news that thousands of seniors with cancer are being denied treatment with expensive chemotherapy drugs as a result of sequestration-mandated budget cuts raises the question of whether other patients are being equally harmed, but less visibly. Read More »

Why Open-Source Principles Are a Recipe For Innovation

April Burbank | Forbes | July 25, 2012

Open sourced software has proven that proprietary ownership often precludes innovation — and that with proper organization and oversight, you can trust the wisdom of the masses. But what does open sourcing look like in health care, government or everyday situations where there is no software code?

Read More »